74 results match your criteria: "The Lions Eye Institute[Affiliation]"
J Drug Target
January 2025
The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Bentley, Western Australia, Australia.
Vision loss and blindness are significant issues in both developed and developing countries. There are a wide variety of aetiologies that can cause vision loss, which are outlined in this review. Although treatment has significantly improved over time for some conditions, nearly half of all people with vision impairment are left untreated.
View Article and Find Full Text PDFAge-related cataracts is a highly prevalent eye disorder that results in the clouding of the crystalline lens and is one of the leading causes of visual impairment and blindness. The disease is influenced by multiple factors including genetics, prolonged exposure to ultraviolet radiation, and a history of diabetes. However, the extent to which each of these factors contributes to the development of cataracts remains unclear.
View Article and Find Full Text PDFOphthalmic Epidemiol
September 2024
Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia.
Purpose: Associations between age at menarche and myopia have been observed in studies that included older women. Furthermore, pregnancy-related hormone surges in young women are associated with short-term changes in refractive error, although the long-term effects are less known. This study explored associations of age at menarche and parity with refractive error and ocular biometry in young women, and the relationship between age at menarche and refractive error in middle-aged adults for comparison.
View Article and Find Full Text PDFInvest Ophthalmol Vis Sci
August 2024
University of Western Australia, Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), Perth, Western Australia, Australia.
Purpose: Few studies have explored choroidal changes after cessation of myopia control. This study evaluated the choroidal thickness (ChT) and choroidal vascularity index (CVI) during and after discontinuing long-term low-concentration atropine eye drops use for myopia control.
Methods: Children with progressive myopia (6-16 years; n = 153) were randomized to receive 0.
Acta Neuropathol Commun
August 2024
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Eye (Lond)
November 2024
Centre for Eye Research Ireland, Environmental Sustainability & Health Institute, Technological University Dublin, Dublin, Ireland.
Clin Exp Ophthalmol
November 2024
Lions Outback Vision, Centre for Ophthalmology and Visual Science, University of Western Australia and the Lions Eye Institute, Perth, Western Australia, Australia.
Background: Patients in rural Australia have limited access to intravitreal treatments due to a maldistribution of the ophthalmology workforce. To improve access, a novel outreach service model was implemented whereby junior medical staff administered intravitreal injections under a supervising ophthalmology consultant. This model involves outreach visits in hospitals, mobile clinics and a remote hub with intravitreal injections administered by junior doctors overseen by an ophthalmologist.
View Article and Find Full Text PDFTaiwan J Ophthalmol
June 2024
Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia.
This study explored the impact of short-term coronavirus disease 2019 (COVID-19) restrictions on the efficacy of atropine 0.01% eyedrops on myopia control in a multiethnic cohort of Australian children. In the Western Australia Atropine for the Treatment of Myopia study, 104 and 49 children were randomized to receive atropine 0.
View Article and Find Full Text PDFTaiwan J Ophthalmol
May 2024
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
We systematically reviewed the literature on the effects of the coronavirus disease 2019 (COVID-19) pandemic on the progression, prevalence, and incidence of myopia. A comprehensive literature search was performed on PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases. Studies included in the review assessed myopia progression, prevalence, and/or incidence as the primary outcome.
View Article and Find Full Text PDFMol Pharm
July 2024
The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Bentley, Perth, Western Australia 6102, Australia.
Oxidative stress is pivotal in retinal disease progression, causing dysfunction in various retinal components. An effective antioxidant, such as probucol (PB), is vital to counteract oxidative stress and emerges as a potential candidate for treating retinal degeneration. However, the challenges associated with delivering lipophilic drugs such as PB to the posterior segment of the eye, specifically targeting photoreceptor cells, necessitate innovative solutions.
View Article and Find Full Text PDFAm J Ophthalmol
September 2024
From the University of Western Australia (S.S.Y.L., S.Y., G.L., D.A.M.), Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), Perth, WA, Australia; Centre for Eye Research Australia (E.C., E.W.C., D.A.M.), University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia; School of Medicine, Menzies Research Institute Tasmania (D.A.M.), University of Tasmania, Hobart, TAS, Australia.
Purpose: This study evaluates the performance of a multitrait polygenic risk score (PRS) in an independent cohort to predict incident or progression of keratoconus.
Design: Prospective cross-sectional and cohort study METHODS: Setting: Single-center; Study population: 1478 community-based young adults (18-30 years; 51% female), including 609 (52% female) who returned for an 8-year follow-up; Observation procedures: Scheimpflug imaging (Pentacam, Oculus), genotyping and development of a multitrait PRS previously validated to predict keratoconus in older adults.; Main outcome measure: Belin/Ambrόsio enhanced ectasia display (BAD-D) score and keratoconus, defined as BAD-D ≥2.
Clin Exp Ophthalmol
July 2024
Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia.
Background: A rebound in myopia progression following cessation of atropine eyedrops has been reported, yet there is limited data on the effects of stopping 0.01% atropine compared to placebo control. This study tested the hypothesis that there is minimal rebound myopia progression after cessation of 0.
View Article and Find Full Text PDFEye (Lond)
May 2024
Centre for Eye Research Ireland, Environmental Sustainability & Health Institute, Technological University Dublin, Dublin, Ireland.
Background/objectives: Axial length, a key measurement in myopia management, is not accessible in many settings. We aimed to develop and assess machine learning models to estimate the axial length of young myopic eyes.
Subjects/methods: Linear regression, symbolic regression, gradient boosting and multilayer perceptron models were developed using age, sex, cycloplegic spherical equivalent refraction (SER) and corneal curvature.
Invest Ophthalmol Vis Sci
November 2023
Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), the University of Western Australia, Perth, Western Australia, Australia.
Purpose: Changes in refractive error during young adulthood is common yet risk factors at this age are largely unexplored. This study explored risk factors for these changes, including gene-environmental interactions.
Methods: Spherical equivalent refraction (SER) and axial length (AL) for 624 community-based adults were measured at 20 (baseline) and 28 years old.
Transl Vis Sci Technol
August 2023
Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia.
Clin Exp Ophthalmol
July 2023
Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), The University of Western Australia, Crawley, Western Australia, Australia.
Invest Ophthalmol Vis Sci
May 2023
CooperVision Inc., Pleasanton, California, United States.
EBioMedicine
May 2023
School of Optometry & Vision Sciences, Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK. Electronic address:
Background: High myopia (HM), defined as a spherical equivalent refractive error (SER) ≤ -6.00 diopters (D), is a leading cause of sight impairment, through myopic macular degeneration (MMD). We aimed to derive an improved polygenic score (PGS) for predicting children at risk of HM and to test if a PGS is predictive of MMD after accounting for SER.
View Article and Find Full Text PDFJAMA Ophthalmol
May 2023
Save Sight Institute, Discipline of Ophthalmology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Eur J Ophthalmol
December 2022
Department of Ophthalmology, 1415University of Auckland, Auckland, New Zealand.
Purpose: To evaluate the agreement between two biometry devices, the Heidelberg Anterion and the Galilei G6 Lens Professional.
Methods: Eyes were scanned with both biometry devices. Analysis of inter-device agreement was conducted for the following metrics: flat (K1), steep (K2) and mean K (Km) for anterior, posterior and total cornea, lens thickness (LT), central corneal thickness (CCT), anterior chamber depth (ACD), white to white (WTW) and axial length (AL).
Clin Exp Optom
March 2023
Centre for Ophthalmology and Visual Science (affiliated with the Lions Eye Institute), University of Western Australia, Perth, Australia.
Clin Exp Ophthalmol
December 2022
Centre for Ophthalmology and Visual Sciences(incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia.
Background: To test the hypothesis that 0.01% atropine eyedrops are a safe and effective myopia-control approach in Australian children.
Methods: Children (6-16 years; 49% Europeans, 18% East Asian, 22% South Asian, and 12% other/mixed ancestry) with documented myopia progression were enrolled into this single-centre randomised, parallel, double-masked, placebo-controlled trial and randomised to receive 0.
Ophthalmology
October 2022
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology), The University of Melbourne, Melbourne, Australia. Electronic address:
Transl Vis Sci Technol
July 2022
Centre for Ophthalmology and Visual Sciences (incorporating the Lions Eye Institute), University of Western Australia, Nedlands, Australia.
Purpose: To explore relationships between patterns of fetal anthropometric growth, as reflective of fetal wellbeing, and global retinal nerve fiber layer (RNFL) thickness measured in young adulthood.
Methods: Participants (n = 481) from within a Western Australian pregnancy cohort study underwent five serial ultrasound scans during gestation, with fetal biometry measured at each scan. Optic disc parameters were measured via spectral-domain optical coherence tomography imaging at a 20-year follow-up eye examination.
Invest Ophthalmol Vis Sci
May 2022
The University of Western Australia, Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), Perth, Western Australia, Australia.
Purpose: The purpose of this study was to explore the age-related change in choroidal thickness (ChT) and test the hypothesis that baseline ChT is predictive of refractive error change in healthy young adults.
Methods: Participants underwent spectral-domain optical coherence tomography (SD-OCT) imaging and autorefraction at 20 (baseline) and 28 years old. The enhanced depth imaging mode on the SD-OCT was used to obtain images of the choroid.